Valneva SE VALN
5.69 USD -0.08 (-1.39%)
Nov 13, 2026, 11:14 AM EST
5.81 Day range 5.88
4.75 52-week range 12.18
- YTD
- -35.49%
- 1 year
- -38.35%
News
benzinga.com Valneva Reports Five-Year Antibody Persistence for Chikungunya Vaccine Valneva SE (NASDAQ:VALN) reported positive five-year antibody persistence results for its single-dose chikungunya vaccine, IXCHIQ, confirming that the shot delivers lasting immune protection across…
benzinga.com Valneva Reports Five-Year Antibody Persistence for Chikungunya Vaccine Valneva reports 94% of adults sustained antibody protection five years after receiving its single-dose chikungunya shot IXCHIQ.
benzinga.com Valneva Says Single-Dose Chikungunya Vaccine IXCHIQ Showed Antibody Persistence Consistent With Prior Results, In Line With Company Expectations, With 94% Seroresponse At Year 5 Across Age Groups 94% of participants maintained seroresponse five years after a single vaccinationComparable antibody persistence observed in older (65+) and younger adultsData further reinforce IXCHIQ®'s…
globenewswire.com Valneva Reports Sustained 94% Seroresponse Five Years After a Single Dose of Chikungunya Vaccine IXCHIQ® Lyon (France), November 10, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported positive five-year antibody persistence data for its single dose…
benzinga.com Valneva Evaluates Next Steps for Bacterial Infection Vaccine Following Successful Phase 2 Studies Valneva SE (NASDAQ:VALN) announced positive data from two Phase 2 clinical trials evaluating Shigella4V2 (S4V2), the world's most clinically advanced tetravalent bioconjugate candidate targeting…
globenewswire.com Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2 Data from infant immunogenicity and safety trial, and controlled human infection model (CHIM) trial, demonstrate favorable safety profile with encouraging immunogenicity and efficacy signals
benzinga.com Full Transcript: Valneva Q2 2026 Earnings Call Valneva (NASDAQ:VALN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For…
benzinga.com UK Revokes Approval for Valneva's Chikungunya Shot UK MHRA revokes Valneva’s IXCHIQ chikungunya vaccine authorization over traveler benefit-risk review. Minimal financial impact expected.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Valneva (NASDAQ:VALN) shares rose 20.6% to $7.09 during Wednesday's after-market session. The company's market cap stands at $555.6 million. Profound Medical (NASDAQ:PROF) stock rose 16.98%…
benzinga.com Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.
benzinga.com Applied Optoelectronics, SanDisk, Seagate And Other Big Stocks Moving Lower In Monday’s Pre-Market Session Stock futures mixed, Nasdaq 100 down 100 points. Applied Optoelectronics falls after announcing $600M offering. Other pre-market losers include RFAI, ZSTK, ZKH, JMIA, VALN, MFI, COHR, SNDK, AXTI,…
benzinga.com European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application Valneva (VALN) stock surges after EMA validates MAA for Lyme disease vaccine candidate developed with Pfizer (PFE). Phase 3 trial showed efficacy and no safety concerns, pending regulatory approval.
benzinga.com Dow Falls Over 100 Points; US Consumer Sentiment Declines In August Dow falls 0.26% while Nasdaq drops 0.51%. Energy shares rise 1.3%, tech stocks fall 0.6%. US retail sales down 0.6%, consumer sentiment declines.
benzinga.com Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Capricor Therapeutics (NASDAQ:CAPR) stock rose 94.8% to $8.2 during Friday's pre-market session. The company's market cap stands at $243.8 million. As per the news, the Q2 earnings report…
benzinga.com Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
benzinga.com Conference Call:
Valneva Affirms FY2026 Sales Guidance of $169.795M-$187.360M vs $171.630M Est Valneva (NASDAQ:VALN) affirms FY2026 sales outlook from $169.795 million-$187.360 million to $169.795 million-$187.360 million vs $171.630 million estimate.
benzinga.com Valneva Reports H1 2026 Product Sales Of €64.0M Down From €91.0M YoY, Net Loss Widens To €63.3M From €20.8M YoY Total product sales of €64.0 millionIn-line with expectations; full-year guidance of €135 -150 million reaffirmedSolid cash position of €121.5 million as of end June 2026Reflects disciplined cash…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global…
- benzinga.com Transcript: Valneva Q1 2026 Earnings Conference Call
- benzinga.com Valneva Lowers FY2026 Sales Guidance from $180.443M-$197.906M to $169.795M-$187.360M vs $192.800M Est Valneva (NASDAQ:VALN) lowers FY2026 sales outlook from $180.443 million-$197.906 million to $169.795 million-$187.360 million vs $192.800 million estimate.
benzinga.com Earnings Scheduled For May 13, 2026 
benzinga.com Valneva Q1 EPS $(0.42) Misses $(0.21) Estimate, Sales $36.189M Miss $46.270M Estimate Valneva (NASDAQ:VALN) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.21) by 100 percent. This is a 223.08 percent decrease over losses of $(0.13)…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 results, cuts FY guidance. Other stocks also down.
benzinga.com Sonoco Products Posts Downbeat Q1 Results, Joins Target Hospitality, Calix And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Dow futures up 250 points. Sonoco Products Co (SON) shares down 5.7% in pre-market after reporting lower-than-expected earnings and sales.
benzinga.com Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial results for miv-cel. Other gainers include HCAI, ELPW, and ALP.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Crude Oil Falls Sharply; Dell Shares Spike Higher Dow up 2.45%, Nasdaq up 2.46%, S&P 500 up 2.19%. Consumer discretionary shares up 3.6%, energy stocks up 0.3%. Dell announces enhancements, BofA raises price target. Apogee up 17%, Tower Semi up 9%,…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive Valneva stock drops after Phase 3 Lyme vaccine misses primary endpoint; secondary data shows efficacy as Pfizer backs regulatory submissions.
benzinga.com Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February Dow Jones rises over 800 points on Monday as U.S. stocks trade higher. NASDAQ and S&P 500 also see gains. Consumer discretionary shares climb, construction spending falls.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session Dow futures up 1000 points. Valneva stock falls in pre-market. Pfizer and Valneva announce Phase 3 results for Lyme disease vaccine. Other stocks also down.
benzinga.com Pfizer, Valneva Report Topline Results From Phase 3 VALOR Clinical Trial Of Investigational 6-Valent OspA-Based Lyme Disease Vaccine Candidate PF-0730740; Trial Shows More Than 70% Efficacy In Preventing Lyme Disease In Individuals Aged Five Years And Above Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and aboveThe investigational vaccine candidate was well tolerated…- benzinga.com Elaris Secures Global License From Valneva For C. difficile Vaccine Tech, Targets Clinical Trials By 2027 Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced an exclusive global license agreement with Valneva SE…
benzinga.com Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Dow futures up 200 points, ClearPoint Neuro (CLPT) stock falls after wider-than-expected quarterly loss. Other stocks moving lower in pre-market.- benzinga.com Earnings Scheduled For March 18, 2026
- benzinga.com Valneva Affirms FY2026 Sales Guidance of $180.443M-$197.906M Valneva (NASDAQ:VALN) affirms FY2026 sales outlook from $180.443 million-$197.906 million to $180.443 million-$197.906 million.
- benzinga.com Valneva Q4 EPS $(0.68) Misses $(0.21) Estimate, Sales $55.516M Miss $56.190M Estimate Valneva (NASDAQ:VALN) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.21) by 221.43 percent. This is a 25 percent decrease over losses of $(0.54) per…
benzinga.com Zepp Health, Endeavour Silver, First Majestic Silver And Other Big Stocks Moving Lower In Monday's Pre-Market Session U.S. stock futures higher, Dow up 100 points. Zepp Health shares fell 11% after reporting losses. Other stocks also declining in pre-market trading.
benzinga.com Why Zevra Therapeutics Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket ZVRA up in pre-market trading on better-than-expected Q4 results. Gainers include BRTX, COOT, BIYA, SOAR, MTEN, MDCX, NXGL, ABTC, and VALN. Losers include GSIW, POM, ARQ, RAIL, and NTZ.
benzinga.com Latham Group, Babcock & Wilcox, B&G Foods And Other Big Stocks Moving Higher On Wednesday Dow falls 100 pts, Latham Group Inc (SWIM) rises 25.7%, Babcock & Wilcox Enterprises Inc (BW) gains 23%, B&G Foods Inc (BGS) rises 20.4%.- benzinga.com Valneva Posts €174.7M In Preliminary 2025 Revenues, Up From €169.6M In 2024, With €109.7M Cash; Guides 2026 Total Revenues Of €155M-€170M, Product Sales €145M-€160M, With Phase 3 Lyme Disease Data Expected In H1 2026 Total Revenues of €174.7 million in line with guidance, including €157.9 million in product salesStrong year-end cash position of €109.7 million, with enhanced financial flexibility following…
benzinga.com Valneva Announces U.K.'s Commission On Human Medicines Restricts People Aged 60+ From Using IXCHIQ Chikungunya Vaccine Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that following a review of the benefits and risks of the Company's single‑dose chikungunya vaccine, IXCHIQ®, the…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Valneva Steps Back From US Approval Bid For Chikungunya Vaccine Valneva withdraws U.S. applications for its chikungunya vaccine Ixchiq after the FDA suspended the license and placed studies on hold following new reports of serious adverse events.
benzinga.com Valneva, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - benzinga.com Reported Monday, Valneva Withdraws IXCHIQ Chikungunya Vaccine BLA And IND In The US Following FDA Suspension And New Serious Adverse Event Review Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and commercial attractiveness
benzinga.com Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday